---
title: "Supply of Mepolizumab (Nucala(r))"
ocid: "ocds-r6ebe6-0000525420"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000525420"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000525420.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000525420.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2018-02-01"
---

# Supply of Mepolizumab (Nucala(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000525420

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000525420)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000525420.json)

## Summary

The procurement process for the supply of Mepolizumab (Nucala®) was conducted by The Common Services Agency (NHS National Services Scotland) based in Edinburgh, UK. This tender is classified under the health industry category and was awarded through a limited procurement method without prior publication of a competition, as the medication is protected by patent. The contract was signed on 22 January 2018, and it allows for delivery to all entities under the National Health Services (Scotland) Act 1978 across Scotland.

This opportunity can significantly benefit businesses in the pharmaceutical sector, particularly those that specialise in patented medicinal products. Companies that can supply Mepolizumab and related healthcare products may find a clear pathway to engage with NHS Scotland, leveraging the framework agreement for potential long-term business growth. With a framework duration extending over four years, there is ample opportunity for interested suppliers to establish a solid relationship with the NHS and expand their market reach.

## Notice

The supply of Mepolizumab (Nucala(r)) to NHSScotland

### Lot Information

Lot 1

This procurement is for the supply of Mepolizumab (Nucala(r)) to NHSScotland. The Authority has awarded a single-supplier framework agreement for the requirement.

### Procurement Information

The medicine awarded to this framework agreement is, and will continue to be, protected by patent for the duration of the framework agreement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB308743 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 1 Feb 2018 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 22 Jan 2018 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 1 Feb 2018 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB308743
- 11 Jan 2018 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN306368

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN306368
  Supply of Mepolizumab (Nucala(r)) - The supply of Mepolizumab (Nucala(r)) to NHSScotland
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB308743
  Supply of Mepolizumab (Nucala(r)) - The supply of Mepolizumab (Nucala(r)) to NHSScotland

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000525420

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000525420. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000525420.json.